Xeris Biopharma Holdings, Inc. (XERS)

NASDAQ: XERS · Real-Time Price · USD

10.48

+0.29 (2.85%)

Oct 9, 2026, 4:00 PM EDT - Market closed

Xeris Biopharma Holdings Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	335.41	291.85	203.07	163.91	110.25	49.59
Revenue Growth	36.33%	43.72%	23.89%	48.68%	122.32%	142.67%
Gross Profit	290.39	249.28	166.24	135.27	87.61	36.27
Operating Income	36.59	24.9	-33.65	-44.01	-81.94	-105.5
Net Income	-17.17	0.55	-54.84	-62.26	-94.66	-122.73
Earnings Per Share	-0.10	0.00	-0.37	-0.45	-0.70	-1.55
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	121.75	111.04	71.62	72.45	121.97	102.43
Total Debt	289.44	258.1	271.45	229.19	198.06	88.07
Net Cash (Debt)	-167.7	-147.06	-199.83	-156.74	-76.09	14.37
Net Cash Growth	-	-	-	-	-	-69.28%
Net Cash Per Share	-1.00	-0.85	-1.36	-1.14	-0.56	0.18

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	56.61	28.63	-36.98	-47.02	-102.89	-95.54
Capital Expenditures	-0.94	-0.7	-0.87	-2.26	-0.52	-1.09
Free Cash Flow	55.67	27.93	-37.85	-49.29	-103.42	-96.62
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	86.58%	85.41%	81.86%	82.52%	79.47%	73.14%
Operating Margin	10.91%	8.53%	-16.57%	-26.85%	-74.32%	-212.74%
Pretax Margin	-5.12%	0.19%	-28.12%	-38.74%	-87.15%	-247.48%
Profit Margin	-5.12%	0.19%	-27.00%	-37.98%	-85.86%	-247.48%
FCF Margin	16.60%	9.57%	-18.64%	-30.07%	-93.80%	-194.84%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	2351.09	-	-	-	-
Forward PE	69.08	64.50	-	-	-	-
P/FCF Ratio	34.32	46.64	-	-	-	-
PS Ratio	5.70	4.46	2.49	1.98	1.64	7.37